News Focus
News Focus
Followers 24
Posts 2702
Boards Moderated 0
Alias Born 10/23/2003

Re: DewDiligence post# 1454

Friday, 07/27/2007 10:41:28 PM

Friday, July 27, 2007 10:41:28 PM

Post# of 3757
dew - Is it already a given that Viread is a better drug in your mind. If so what if Ns+Nt are not succesful. It seems like a bit less then a 50/50 to me.

Thank you!

Randy



Bad for IDIX: Viread is a better drug than Hepsera and hence a stronger rival to Tyzeka for monotherapy.

Good for IDIX: Viread is a better drug than Hepsera and hence it raises the probability that Ns+Nt combination therapy will be successful. This, in turn, will increase the overall number of HBV patients who are treated.